{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:01Z","timestamp":1788415981426,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To analyze the clinicopathological features, surgical management, and long-term prognosis of a composite pheochromocytoma (CP; pheochromocytoma combined with ganglioneuroma) arising 13 years after resection of a primary adrenal pheochromocytoma, with the aim of improving the clinical diagnosis and management of this rare neoplasm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 61-year-old Han male had undergone left adrenal pheochromocytoma resection 13 years prior to the current presentation. An asymptomatic left adrenal nodule was incidentally detected during a routine physical examination, and the patient was subsequently admitted to the Department of Urology at The Third Hospital of Mianyang. He denied any history of other chronic systemic illnesses. Admission biochemistry revealed only a mild elevation of epinephrine, with the concentration remaining below twice the upper limit of normal. Abdominopelvic contrast-enhanced computed tomography (CT) identified a well-circumscribed hypodense nodule measuring 2.6 \u00d7 2.1\u00a0cm beneath the left adrenal gland, demonstrating marked nodular and peripheral ring enhancement; a separate hypodense nodule with a maximum diameter of 1.8\u00a0cm was also noted in the right adrenal fossa. Based on his disease history and imaging findings, recurrence of left adrenal pheochromocytoma was strongly suspected, and a synchronous right adrenal pheochromocytoma could not be excluded. The patient consented only to partial left adrenalectomy. Intraoperative exploration revealed adhesions among the descending colon, peritoneum, and spleen, as well as multiple solid masses (maximum size 2.0 \u00d7 2.0\u00a0cm) in the left adrenal region that were densely adherent to the pancreatic parenchyma. The resected specimens were submitted for pathological evaluation. Histopathological examination confirmed a composite pheochromocytoma with cystic change, multifocal coagulative necrosis, and adipose tissue invasion. The patient experienced an uneventful postoperative recovery. During the subsequent 11-month follow-up period, no recurrence or distant metastasis was detected, and the patient remained clinically stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      It remains challenging to definitively establish whether the left adrenal composite pheochromocytoma (CP) detected in this patient represents true tumor recurrence 13 years after the initial surgery. Archival pathological slides from the primary operation were unavailable for comparative histologic and clonal analysis. Moreover, the original lesion was diagnosed as a pure pheochromocytoma, whereas the current mass harbors an additional mature ganglioneuromatous component displaying distinct histological features. Given the lack of evaluable surgical margins from the initial partial adrenalectomy, the possibility of minimal residual disease cannot be excluded. Accordingly, two possibilities are proposed: late ipsilateral recurrence of the original chromaffin tumor, or a metachronous\n                      <jats:italic>de novo<\/jats:italic>\n                      primary CP arising independently in the left adrenal gland. In contrast to most previously documented CP cases, this patient exhibited isolated mild epinephrine elevation without catecholamine-related clinical manifestations, underscoring that regular physical screening and postoperative histopathology constitute the main diagnostic pillars. Surgical resection remains the first-line therapy. Regardless of its origin, long-term regular surveillance is mandatory, given the inherent metastatic potential of pheochromocytomas and paragangliomas (PPGLs).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1784221","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:18:25Z","timestamp":1788412705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A case report of a composite pheochromocytoma that occurred 13 years after adrenalectomy for pheochromocytoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Min","family":"Min","sequence":"first","affiliation":[{"name":"Department of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center","place":["Mianyang, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Third Hospital of Mianyang, Sichuan Mental Health Center","place":["Mianyang, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-xi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, The Third Hospital of Mianyang, Sichuan Mental Health Center","place":["Mianyang, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center","place":["Mianyang, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03492-y","article-title":"Composite pheochromocytoma of the adrenal gland-a review of published cases","volume":"483","author":"Costa","year":"2023","journal-title":"Virchows Arch"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4158\/EP14010.OR","article-title":"Clinical and radiologic features of pheochromocytoma\/ganglioneuroma composite tumors: a case series with comparative analysis","volume":"20","author":"Shawa","year":"2014","journal-title":"Endocr Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9494-3","article-title":"Composite pheochromocytoma\/paraganglioma-ganglioneuroma: a clinicopathologic study of eight cases with analysis of succinate dehydrogenase","volume":"28","author":"Gupta","year":"2017","journal-title":"Endocr Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3892\/etm.2021.10773","article-title":"Adrenal ganglioneuroma: prognostic factors (review)","volume":"22","author":"Sandru","year":"2021","journal-title":"Exp Ther Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-021-02129-5","article-title":"Composite phaeochromocytomas-a systematic review of published literature","volume":"407","author":"Dhanasekar","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.903085","article-title":"Case report: Composite pheochromocytoma with ganglioneuroma component: a report of three cases","volume":"13","author":"Araujo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1734-x","article-title":"Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center","volume":"62","author":"Falhammar","year":"2018","journal-title":"Endocrine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4103\/ijemcr.ijemcr_56_24","article-title":"Adrenal neurofibroma masquerading as phaeochromocytoma","volume":"2","author":"Arjunan","year":"2024","journal-title":"IJEM Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4158\/EP09205.RA","article-title":"Composite pheochromocytoma-ganglioneuroma: a rare experiment of nature","volume":"16","author":"Khan","year":"2010","journal-title":"Endocr Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/ijemcr.ijemcr_2_25","article-title":"Silent catalyst: undiagnosed pheochromocytoma triggering acute aortic dissection","volume":"3","author":"Sangdup","year":"2025","journal-title":"IJEM Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2013.796103","article-title":"Hormone-secreting large adrenal ganglioneuroma in an adult patient: a case report and review of literature","volume":"23","author":"Erem","year":"2014","journal-title":"Blood Press"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7796.110011","article-title":"Composite pheochromocytoma-ganglioneuroma of the adrenal gland: a case report with immunohistochemical study","volume":"5","author":"Rao","year":"2013","journal-title":"Urol Ann"},{"key":"B14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2026.05.008","article-title":"Composite pheochromocytomas: more common than expected and associated with distinct clinical profile","author":"Zawadzka","year":"2026","journal-title":"Endocr Pract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00234","article-title":"A novel MAX gene mutation variant in a patient with multiple and \"composite\" neuroendocrine-neuroblastic tumors","volume":"11","author":"Pozza","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2478\/enr-2019-0020","article-title":"Pheochromocytoma","volume":"53","author":"Farrugia","year":"2019","journal-title":"Endocr Regul"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09632-3","article-title":"Images in endocrine pathology: progressive loss of sustentacular cells in a case of recurrent jugulotympanic paraganglioma over a span of 5 years","volume":"31","author":"Zhou","year":"2020","journal-title":"Endocr Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002238","article-title":"Validation and evaluation of 5 scoring systems for predicting metastatic risk in pheochromocytoma and paraganglioma","volume":"48","author":"Li","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2478312","article-title":"Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas","volume":"57","author":"Luo","year":"2025","journal-title":"Ann Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2169\/internalmedicine.39.58","article-title":"Results of surgery for a compound adrenal tumor consisting of pheochromocytoma and ganglioneuroblastoma in an adult: 5-year follow-up","volume":"39","author":"Fujiwara","year":"2000","journal-title":"Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02553-5","article-title":"COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas\/paragangliomas","volume":"474","author":"Pierre","year":"2019","journal-title":"Virchows Arch"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1784221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:18:25Z","timestamp":1788412705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1784221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":22,"alternative-id":["10.3389\/fonc.2026.1784221"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1784221","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1784221"}}